Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs morphine for postoperative moderate-to-severe pain
CTR20211608Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine in postoperative pain, labor pain, None, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Jul 2021; status: completed.
02
Drugs
nalbuphine
03
Conditions
postoperative painlabor pain
Beyond the preview
Go deeper on CTR20211608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211608.